Company Filing History:
Years Active: 2011
Title: Jørgen Martin De Jonge: Innovator in Virosome Technology
Introduction
Jørgen Martin De Jonge is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of virosome technology, which has implications for vaccine development and drug delivery systems. His innovative approach has led to the creation of a unique patent that showcases his expertise in this area.
Latest Patents
Jørgen holds a patent for "Virosome-like-particles." This invention relates to the production of virosome-like particles, providing a method for producing these particles by contacting an enveloped virus with a solution containing a short-chain phospholipid. This process allows for the solubilization of the viral envelope, and subsequently, the removal of the short-chain phospholipid enables the formation of a functionally reconstituted viral envelope. He has 1 patent to his name.
Career Highlights
Throughout his career, Jørgen has been associated with Bestewil Holding B.V., where he has been able to apply his innovative ideas in a practical setting. His work has not only advanced the understanding of virosome technology but has also contributed to the development of new methodologies in the field.
Collaborations
Jørgen has collaborated with several professionals in his field, including Anke Luise Wilhelmine Huckriede and Antonius Johannes Hendrikus Stegmann. These collaborations have enriched his research and have led to further advancements in virosome technology.
Conclusion
Jørgen Martin De Jonge is a pioneering inventor whose work in virosome technology has the potential to impact various medical applications. His innovative methods and collaborations highlight his commitment to advancing scientific knowledge and technology.